Package Leaflet: Information for the User
Suliqua 100 units/ml + 33 micrograms/ml solution for injection in pre-filled pen
Insulin glargine + lixisenatide
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
Suliqua is an injectable medicine for diabetes that contains two active substances:
Suliqua is used to treat adult patients with type 2 diabetes to help control blood sugar levels when they are too high, as an addition to diet and exercise. It is given with metformin with or without sodium-glucose cotransporter-2 (SGLT2) inhibitors (gliflozins), when other medicines are not enough to control blood sugar levels.
Do not use Suliqua
Warnings and precautions
Talk to your doctor, pharmacist, or nurse before you start using Suliqua if:
Follow your doctor's instructions exactly regarding dosage, monitoring (blood and urine tests), diet, and physical activity (work and exercise) and injection technique.
You must pay special attention to the following:
While using this medicine, pay attention to the following and consult your doctor, pharmacist, or nurse before using Suliqua if:
Skin changes at the injection site
The injection site should be rotated to avoid skin changes, such as lumps under the skin. Insulin may not work as well if injected into a lumpy area (see How to use Suliqua). Contact your doctor if you are currently injecting into a lumpy area before starting to inject into a different area. Your doctor may advise you to check your blood sugar levels more closely and adjust your insulin or other diabetes medicines.
Travel
Before traveling, consult your doctor. You may need to discuss:
Children and adolescents
There is no experience with the use of Suliqua in children and adolescents under 18 years of age; therefore, the use of Suliqua is not recommended in this age group.
Other medicines and Suliqua
Tell your doctor, pharmacist, or nurse if you are taking, have recently taken, or might take any other medicines. If you use another diabetes medicine, consult your doctor if you should stop using that medicine when you start treatment with Suliqua.
Some medicines may change your blood sugar level. This may mean that your doctor may need to change your dose of Suliqua. Therefore, before taking a medicine, ask your doctor if it will affect your blood sugar level and what action to take if necessary. You also need to be careful when you stop taking a medicine.
The effect of some of the medicines you take may be affected by Suliqua. You may need to take some medicines, such as antibiotics, oral contraceptives, statins (such as atorvastatin to lower cholesterol), tablets, capsules, granules, powders, or oral suspensions that should not stay in your stomach for too long, at least 1 hour before or 4 hours after injecting Suliqua.
Your blood sugar level may decrease (hypoglycemia) if you take:
Your blood sugar level may increase (hyperglycemia) if you take:
Your blood sugar level may increase or decrease if you take:
Medicines that may reduce the warning signs of low blood sugar
Betablockers and some medicines (such as clonidine, guanethidine, reserpine - for high blood pressure) may make it more difficult to recognize the warning signs of low blood sugar (hypoglycemia). They may even hide or interrupt the early signs that your blood sugar level is too low.
If any of the above applies to you (or you are not sure), contact your doctor, pharmacist, or nurse before using this medicine.
Warfarin and other anticoagulants
Tell your doctor if you are taking warfarin or other anticoagulants (medicines used to prevent blood clots), as you may need to have blood tests more frequently to check your blood clotting (called "International Normalized Ratio" or INR control).
Suliqua and alcohol
Your blood sugar levels may rise or fall if you drink alcohol. You should check your blood sugar level more often.
Pregnancy and breastfeeding
Suliqua must not be used during pregnancy. It is not known if Suliqua harms your fetus.
Suliqua must not be used during breastfeeding. It is not known if Suliqua passes into breast milk.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
Driving and using machines
Low or high blood sugar levels (see the information in the box at the end of this leaflet) may affect your ability to drive and use tools or machines. Your concentration may be affected. This can be dangerous for you and others.
Ask your doctor if you can drive if:
Suliqua contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per dose, which is essentially "sodium-free".
Suliqua contains metacresol
This medicine contains metacresol, which may cause allergic reactions.
Follow your doctor's instructions exactly regarding the administration of this medicine. Your doctor may tell you to use a different dose of Suliqua than your previous dose of insulin or your glucose-lowering medicine, if you use one. If you are in doubt, ask your doctor, pharmacist, or nurse.
Depending on your lifestyle, blood sugar control, and previous insulin, your doctor will tell you:
Your doctor may tell you to use Suliqua with other medicines for high blood sugar.
How much to use
Suliqua 100 units/ml + 33 micrograms/ml solution for injection in pre-filled pen:
Your dose of Suliqua is given in "dose steps". The dose window of the pen shows the number of dose steps.
Do not inject a dose less than 30 dose steps. Do not inject a dose more than 60 dose steps.
If you need a dose less than 30 dose steps, your doctor will prescribe a different presentation. For dose steps of 10-40 units, use Suliqua 100 units/ml + 50 micrograms/ml solution for injection in pre-filled pen.
Many factors can influence your blood sugar level. You should know these factors so that you can react correctly to changes in your blood sugar level and prevent it from rising or falling too much. For more information, see the box at the end of this leaflet.
Use in elderly patients (65 years and older)
If you are 65 years or older, inform your doctor, as you may need a lower dose.
If you have kidney or liver problems
If you have kidney or liver problems, inform your doctor, as you may need lower doses.
When to inject Suliqua
Use Suliqua once a day, within the hour before a meal. Preferably inject Suliqua before the same meal every day, when you have chosen the most suitable meal.
Before injecting Suliqua
To avoid errors, always check the packaging and label of the pen before each injection to ensure you have the correct pen, especially if you inject more than one medicine.
If you are in doubt, ask your doctor or pharmacist.
How to inject
Do not use Suliqua
Other important information about using pre-filled pens
Never use a syringe to withdraw the solution from the pen, to avoid dosing errors and potential overdosing.
If your pen is damaged, has not been stored correctly, if you are not sure it is working correctly, or if you notice that your blood sugar control is getting worse for no apparent reason:
If you use more Suliqua than you should
If you have injected too much medicine, your blood sugar level may drop too much (hypoglycemia). Check your blood sugar level and eat more to prevent your blood sugar level from dropping too much (hypoglycemia). If your blood sugar level drops too much, see the box at the end of this leaflet.
If you forget to use Suliqua
If you have missed a dose of Suliqua or if you have not injected enough insulin, your blood sugar level may rise too much (hyperglycemia):
When necessary, Suliqua can be injected before the next meal.
If you stop using Suliqua
Do not stop your treatment without consulting your doctor. If you do, it may lead to very high blood sugar levels (hyperglycemia) and an increase in blood acid (ketoacidosis).
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine may cause adverse effects, although not all people suffer from them.
If you notice signs that your blood sugar level is too low (hypoglycemia),act immediately to raise your blood sugar level (see the box at the end of this prospectus).
Hypoglycemia can be very serious and is very common with medicines that contain insulin (it can affect more than 1 in 10 people).
Low blood sugar means that there is not enough sugar in the blood.
If your blood sugar level drops too low, you may faint (lose consciousness).
If the blood sugar level continues to be very low for too long, it can cause brain damage and can be potentially fatal. For more information, see the box at the end of this prospectus.
Other Adverse Effects
Inform your doctor, pharmacist, or nurse if you notice any of the following adverse effects:
If insulin is injected too frequently in the same place, the fatty tissue can shrink (lipoatrophy) or become thicker (lipohypertrophy). Lumps under the skin can also occur due to the accumulation of a protein called amyloid (cutaneous amyloidosis). It is unknown how often these skin changes can occur. Insulin may not work very well if injected into a lumpy area. Change the injection site to help avoid these skin changes.
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect 1 in 1000 people)
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the national reporting system included in Appendix V. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging and on the label of the pen after CAD. The expiration date is the last day of the month indicated.
Before First Use
Store in the refrigerator (between 2 °C and 8 °C).
Do not freeze or place near the freezer compartment or a cold accumulator.
Keep the preloaded pen in the outer packaging to protect it from light.
After First Use or if Carried as a Reserve
Keep your pen in use below 25 °C for a maximum of 28 days. Discard the pen after this period.
Do not put the pen back in the refrigerator and do not freeze it. Keep the pen away from direct heat and direct light. Always put the pen cap on when not in use to protect it from light.
Do not leave the pen in a car on an exceptionally hot or cold day.
Do not store the pen with the needle attached.
Medicines should not be disposed of through wastewater or household waste. Ask your pharmacist how to dispose of packaging and medicines that are no longer needed. This will help protect the environment.
What Suliqua contains
Each pen contains 300 units of insulin glargine and 100 micrograms of lixisenatide in 3 ml of solution.
Each ml contains 100 units of insulin glargine and 33 micrograms of lixisenatide.
Each dose step of Suliqua contains 1 unit of insulin glargine and 0.33 micrograms of lixisenatide.
Appearance and packaging of the product
Suliqua is an injectable solution (injection), clear and colorless in a glass cartridge within a pre-filled pen (SoloStar).
Packaging of 3, 5, and 10 pre-filled pens.
Only some pack sizes may be marketed.
Needles are not included in this packaging.
Marketing authorization holder
Sanofi Winthrop Industrie
82 avenue Raspail
94250 Gentilly
France
Manufacturer
Sanofi-Aventis Deutschland GmbH
Industriepark Höchst - 65926 Frankfurt am Main
Germany
You can request more information about this medicinal product by contacting the local representative of the marketing authorization holder:
België/Belgique/Belgien Sanofi Belgium Tel: +32 (0)2 710 54 00 | Lietuva Swixx Biopharma UAB Tel: +370 5 236 91 40 |
Swixx Biopharma EOOD Tel: +359 (0)2 4942 480 | Luxembourg/Luxemburg Sanofi Belgium Tel: +32 (0)2 710 54 00 (Belgique/Belgien) |
Ceská republika Sanofi s.r.o. Tel: +420 233 086 111 | Magyarország SANOFI-AVENTIS Zrt. Tel: +36 1 505 0050 |
Danmark Sanofi A/S Tlf: +45 45 16 70 00 | Malta Sanofi S.r.l. Tel: +39 02 39394275 |
Deutschland Sanofi-Aventis Deutschland GmbH Tel: 0800 52 52 010 Tel from abroad: +49 69 305 21 131 | Nederland Sanofi B.V. Tel: +31 20 245 4000 |
Eesti Swixx Biopharma OÜ Tel: +372 640 10 30 | Norge sanofi-aventis Norge AS Tlf: +47 67 10 71 00 |
Ελλάδα Sanofi-Aventis Μονοπρ?σωπη ΑΕΒΕ Τηλ: +30 210 900 16 00 | Österreich sanofi-aventis GmbH Tel: +43 1 80 185 – 0 |
España sanofi-aventis, S.A. Tel: +34 93 485 94 00 | Polska Sanofi Sp. z o.o. Tel: +48 22 280 00 00 |
France Sanofi Winthrop Industrie Tél: 0 800 222 555 Appel depuis l’étranger : +33 1 57 63 23 23 | Portugal Sanofi - Produtos Farmacêuticos, Lda Tel: +351 21 35 89 400 |
Hrvatska Swixx Biopharma d.o.o. Tel: +385 1 2078 500 | România Sanofi Romania SRL Tel: +40 (0) 21 317 31 36 |
Ireland sanofi-aventis Ireland Ltd. T/A SANOFI Tel: +353 (0) 1 403 56 00 | Slovenija Swixx Biopharma d.o.o. Tel: +386 1 235 51 00 |
Ísland Vistor hf. Sími: +354 535 7000 | Slovenská republika Swixx Biopharma s.r.o. Tel: +421 2 208 33 600 |
Italia Sanofi S.r.l. Tel: 800 131212 (technical questions) 800 536389 (other questions) | Suomi/Finland Sanofi Oy Puh/Tel: +358 (0) 201 200 300 |
Κύπρος C.A. Papaellinas Ltd. Τηλ: +357 22 741741 | Sverige Sanofi AB Tel: +46 (0)8 634 50 00 |
Latvija Swixx Biopharma SIA Tel: +371 6 616 47 50 | United Kingdom (Northern Ireland) sanofi-aventis Ireland Ltd. T/A SANOFI Tel: +44 (0) 800 035 2525 |
Date of last revision of this leaflet:<{MM/AAAA}><{month YYYY}>.
Other sources of information
Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu/
HYPERGLYCEMIA AND HYPOGLYCEMIA
If you are taking insulin, you should always carry:
Hyperglycemia (high blood sugar levels)
If your blood sugar level is too high (hyperglycemia), you may not have injected enough insulin.
Reasons why hyperglycemia may occur
Some examples:
Warning signs of hyperglycemia:
Thirst, increased need to urinate, fatigue, dry skin, redness of the face, loss of appetite, low blood pressure, rapid heartbeat, and presence of glucose and ketone bodies in the urine. Stomach pain, deep and rapid breathing, feeling sleepy or fainting (loss of consciousness) may be signs of a serious condition (ketoacidosis) caused by lack of insulin.
What to do if you experience hyperglycemia
Hypoglycemia (low blood sugar levels)
If your blood sugar level drops too low, you may faint (lose consciousness). Severe hypoglycemia can cause a heart attack or brain damage and can be life-threatening. You should learn to recognize the signs that indicate your blood sugar level is dropping, so you can take the necessary measures to prevent the situation from getting worse.
Reasons why hypoglycemia may occur
Some examples:
It is also more likely to experience hypoglycemia if:
Warning signs of hypoglycemia:
The first signs can be generally in your body. Examples of signs that your blood sugar level is dropping too low or too quickly are: sweating, moist and sticky skin, anxiety, rapid and irregular heartbeat, high blood pressure, and palpitations. These signs often occur before the signs of low blood sugar in the brain appear.
The signs in your brain include: headache, feeling very hungry, nausea, vomiting, feeling tired, sleepiness, agitation, sleep problems, aggressive behavior, difficulty concentrating, reduced reaction capacity, depression, feeling confused, difficulty speaking (sometimes, complete loss of speech), change in vision, tremors, inability to move (paralysis), tingling in hands or arms, feeling numb and tingling often around the mouth, feeling dizzy, loss of self-control, inability to take care of oneself, seizures, loss of consciousness.
Situations in which the signs of hypoglycemia may be less clear:
The first warning signs of hypoglycemia may change, weaken, or be absent if:
In these cases, you may experience severe hypoglycemia (and even faint) before you realize what is happening. Always be familiar with your warning signs. If necessary, you may need to perform blood sugar tests more frequently. This can help identify mild hypoglycemic episodes. If you have difficulty recognizing your warning signs, you should avoid situations (such as driving a car) that could put you or others at risk due to hypoglycemia.
What to do if you experience hypoglycemia
With Suliqua, recovery from low blood sugar may be delayed because it contains a long-acting insulin (insulin glargine).
What others should do if you experience hypoglycemia
Inform your family, friends, and people close to you that you need urgent medical help if you are unable to swallow or if you faint (lose consciousness).
You will need glucose or glucagon (a medication that increases blood sugar levels). It should be administered even if you are not sure if you are experiencing hypoglycemia.
You should check your blood sugar level immediately after ingesting glucose to confirm that you are actually experiencing hypoglycemia.
Suliqua 100 units/ml + 33 micrograms/ml solution for injection in pre-filled pen (30-60).
INSTRUCTIONS FOR USE
Read the Leaflet and these Instructions for Use before the first use of Suliqua
Suliqua (30-60) SoloStar contains insulin glargine and lixisenatide. The combination of medications in this pen is for daily injection of 30 to 60 dose steps of Suliqua.
Keep these Instructions for Use for future reference.
Important information
Learning to inject
Do you need help?
If you have questions about Suliqua, the pen, or diabetes, ask your doctor, pharmacist, or nurse.
Additional items you will need:
Injection sites
Get to know your pen
STEP 1: Check your pen
For the first use of a new pen, take a new pen out of the refrigerator at least 1hour before your injection. Injecting the medication when it is cold is more painful. After use, the pen will be stored below 25°C.
STEP 2: Attach a new needle
If you try to put it back on, you may accidentally prick yourself with the needle.
Handling needles
STEP 3: Perform a safety test
Always perform a safety test before each injection to:
How to read the dose window
The even numbers are displayed in line with the dose indicator, and the odd numbers are displayed as a line between the even numbers.
39 units selected
Medication units in your pen
STEP 5: Inject the dose
STEP 6: Remove the needle
Hold the wider part of the outer needle cap. Keep the needle straight and direct it towards the outer needle cap. Then press firmly.
How to store your pen
Before first use
After first use
How to care for your pen
Treat your pen with care
Protect your pen from dust and dirt
Disposing of your pen